Detalles de la búsqueda
1.
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
Cancer Immunol Immunother
; 61(3): 373-84, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21927947
2.
A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma.
J Transl Med
; 8: 8, 2010 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20109232
3.
The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.
Gulf J Oncolog
; 1(32): 71-87, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342923
Resultados
1 -
3
de 3
1
Próxima >
>>